Wet AMD Therapies
Sep 15, 2025
The Race for Next-generation Wet AMD Therapies: Shaping the Future of Vision
Neovascular age-related macular degeneration (nAMD or Wet AMD) is a progressive retinal condition and a primary cause of central vision loss among individuals over 60 years old. While it represents only 10–15% of overall AMD cases, it is responsible for nearly 90% of severe vision impairment linked to the disease. ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
